Scholar Rock Holding (SRRK) Enterprise Value Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.72% |
| Dec 31, 2025 | 15.94% |
| Sep 30, 2025 | -165.80% |
| Jun 30, 2025 | -54.87% |
| Mar 31, 2025 | -52.82% |
| Dec 31, 2024 | -56.21% |
| Sep 30, 2024 | 36.39% |
| Jun 30, 2024 | 23.41% |
| Mar 31, 2024 | 13.39% |
| Dec 31, 2023 | 11.23% |
| Sep 30, 2023 | 36.38% |
| Jun 30, 2023 | 32.90% |
| Mar 31, 2023 | -30.96% |
| Dec 31, 2022 | -24.65% |
| Sep 30, 2022 | -39.45% |
| Jun 30, 2022 | -31.35% |
| Mar 31, 2022 | 33.20% |
| Dec 31, 2021 | 25.81% |
| Sep 30, 2021 | -111.96% |
| Jun 30, 2021 | -99.90% |
| Mar 31, 2021 | -95.89% |
| Dec 31, 2020 | -116.60% |
| Sep 30, 2020 | 33.97% |
| Jun 30, 2020 | 23.74% |
| Mar 31, 2020 | -0.62% |
| Dec 31, 2019 | 10.36% |
| Sep 30, 2019 | -69.33% |
| Jun 30, 2019 | -60.90% |
| Dec 31, 2018 | -203.05% |